Search results for "FDA"

showing 10 items of 24 documents

GAMs and functional kriging for air quality data

2016

Data having spatio-temporal structure are often observed in environmental sciences. They may be considered as discrete observations from curves along time and/or space and treated as functional. Generalized Additive Models (GAMs) represent a useful tool for modelling, for example, as pollutant concentrations describing their spatial and/or temporal trends.Usually, the prediction of a curve at an unmonitored site is necessary and, with this aim, we extend kriging for functional data to a multivariate context. Moreover, even if we are interested only in predicting a single pollutant, such as PM10, the estimation can be improved exploiting its correlation with the other pollutants. Cross valid…

FDA GAM OKFD
researchProduct

Comparing Spatial and Spatio-temporal FPCA to Impute Large Continuous Gaps in Space

2018

Multivariate spatio-temporal data analysis methods usually assume fairly complete data, while a number of gaps often occur along time or in space. In air quality data long gaps may be due to instrument malfunctions; moreover, not all the pollutants of interest are measured in all the monitoring stations of a network. In literature, many statistical methods have been proposed for imputing short sequences of missing values, but most of them are not valid when the fraction of missing values is high. Furthermore, the limitation of the methods commonly used consists in exploiting temporal only, or spatial only, correlation of the data. The objective of this paper is to provide an approach based …

Functional principal component analysisComplete dataMultivariate statisticsLong gapComputer sciencecomputer.software_genreMissing dataCorrelationFDA FPCA GAM P-splinesData analysisData miningImputation (statistics)Settore SECS-S/01 - Statisticacomputer
researchProduct

In Vitro Techniques

2006

Driven in part by the development of genomics, proteomics, and bioinformatics as new disciplines, there has been a tremendous resurgence of interest in physical methods to investigate macromolecular structure and function in the context of living cells. This volume in Methods in Cell Biology is devoted to biophysical techniques in vitro and their applications to cellular biology. The volume covers methods-oriented chapters on fundamental as well as cutting-edge techniques in molecular and cellular biophysics.This book is directed toward the broad audience of cell biologists, biophysicists, pharmacologists, and molecular biologists who employ classical and modern biophysical technologies or …

GeneticsIn Vitro TechniquesFda approvalGenomicsContext (language use)Full colorBiologyDrug formulationsData scienceStructure and function
researchProduct

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

2020

According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored al…

ISAR International Severe Asthma RegistrySHARPPediatricsSevere asthmaSA severe asthmaBiologics Oral corticosteroids Real-life Registr Severe asthmaOmalizumabforced expiratory volume in the 1st secondFood &ampGrading of Recommendations Assessmentchronic rhinosinusitis with nasal polyposisFEV1chemistry.chemical_compound0302 clinical medicineQuality of lifeEMAReal WorldEuropean Medicines AgencyBiologics; Oral corticosteroids; Real-life; Registr; Severe asthmaOral corticosteroidsFDA Food & Drug AdministrationImmunology and Allergy030223 otorhinolaryngologySevere Heterogeneous Asthma Research collaborationmusculoskeletal neural and ocular physiologyReal-lifeCRSwNPOCSsBenralizumabDupilumabCRSwNP chronic rhinosinusitis with nasal polyposisGRADESHARP Severe Heterogeneous Asthma Research collaboration Patient-centredSevere Asthma Network in ItalyFDAmedicine.drugPulmonary and Respiratory Medicinelcsh:Immunologic diseases. Allergymedicine.medical_specialtyDrug AdministrationGINA Global Initiative for AsthmaRW Real WorldImmunologymacromolecular substancesRWSettore MED/10 - Malattie Dell'Apparato RespiratorioBiologicsInternational Severe Asthma RegistryISAR03 medical and health sciencesSADisease registrySARP Severe Asthma Research ProgramPatient-centredmedicineAsthmabusiness.industrySettore MED/09 - MEDICINA INTERNASANI Severe Asthma Network in ItalySANIBiological productmedicine.diseaseOCSs Oral CorticoSteroidsGINASARPSevere Asthma Research ProgramFEV1 forced expiratory volume in the 1st second030228 respiratory systemchemistrynervous systemRegistrEMA European Medicines AgencyDevelopment and EvaluationSevere asthma Biologics Oral corticosteroids Real-life Registrbusinesslcsh:RC581-607Global Initiative for AsthmaMepolizumabGRADE Grading of Recommendations Assessment Development and Evaluation
researchProduct

FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022

2023

The inclusion of fluorine atoms or heterocyclic moiety into drug structures represents a recurrent motif in medicinal chemistry. The combination of these two features is constantly appearing in new molecular entities with various biological activities. This is demonstrated by the increasing number of newly synthesized fluorinated heterocyclic compounds among the Food and Drug Administration FDA-approved drugs. In this review, the biological activity, as well as the synthetic aspects, of 33 recently FDA-approved fluorinated heterocyclic drugs from 2016 to 2022 are highlighted.

Inorganic ChemistryheterocyclesfluorineOrganic ChemistryGeneral MedicineSettore CHIM/06 - Chimica OrganicaPhysical and Theoretical ChemistryMolecular BiologyFDA-approvedSpectroscopyCatalysisComputer Science Applications
researchProduct

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

2016

BACKGROUND The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious asthma-related events associated with LABAs. This study was designed to evaluate the risk of administering the LABA salmeterol in combination with an inhaled glucocorticoid, fluticasone propionate. METHODS In this multicenter, randomized, double-blind trial, adolescent and adult patients (age, ≥12 years) with persistent asthma were assigned to receive either fluticasone with salmeterol or fluticasone alone for 26 weeks. All the patients had a history of a severe asthma exacerbation in t…

Maleasthma ; serious events ; fluticasone ; salmeterol ; AUSTRIExacerbationIntention to Treat AnalysiINHALED CORTICOSTEROIDSSeverity of Illness Indexlaw.invention0302 clinical medicineRandomized controlled triallawimmune system diseasesÚs terapèuticBroncodilatadors030212 general & internal medicineChildFluticasoneRISKACTING BETA-AGONISTS; INHALED CORTICOSTEROIDS; RISK; EXACERBATIONS; METAANALYSIS; MORTALITY; SAFETY; DEATH; FDAMedicine (all)Hazard ratioDEATHGeneral MedicineBronchodilator agentsMiddle AgedFluticasone-Salmeterol Drug CombinationBronchodilator AgentsIntention to Treat AnalysisAnesthesiaSAFETYFemaleSalmeterolFDAmedicine.drugHumanAdultmedicine.medical_specialtyAdolescentSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionate03 medical and health sciencesDouble-Blind MethodInternal medicineAdministration InhalationmedicineHumansMETAANALYSISAsmaBronchodilator AgentAsthmaAgedProportional Hazards ModelsFluticasone-Salmeterol Drug Combinationbusiness.industryMORTALITYACTING BETA-AGONISTSTherapeutic usemedicine.diseaseAsthmarespiratory tract diseasesEXACERBATIONS030228 respiratory systemFluticasone Propionate Salmeterol Xinafoate Drug CombinationProportional Hazards ModelFluticasonebusiness
researchProduct

The effect of the valence of forgiveness to service recovery strategies and service outcomes in food delivery apps

2022

The literature offers valuable insights into various aspects of service recovery and service outcomes. However, the available findings are limited relative to the size of the ever-expanding service economy. In particular, past studies have left more granular nuances of the association between service recovery strategies and service outcomes, such as the mediating role of forgiveness or the valence of forgiveness, under-explored. Recognising that an improved understanding of recovery from failures is crucial for sustaining positive customer–brand relationships in the service economy, the present study investigates the mediating effect of the valence of forgiveness (both exoneration and resen…

MarketingLOYALTYROLESBrand trust:Samfunnsvitenskap: 200::Økonomi: 210::Bedriftsøkonomi: 213 [VDP]Service recoveryINTENTIONFood delivery apps (FDAs)VDP::Samfunnsvitenskap: 200::Økonomi: 210MODELEXPLORATIONøkonomiCONTEXTWORD-OF-MOUTHForgivenesssTheory of stress and copingNegative word of mouth (NWOM)FAILURECUSTOMER SATISFACTIONTRUST512 Business and Managementmatapperhealth care economics and organizations
researchProduct

Empirical Orthogonal Function and Functional Data Analysis Procedures to Impute Long Gaps in Environmental Data

2016

Air pollution data sets are usually spatio-temporal multivariate data related to time series of different pollutants recorded by a monitoring network. To improve the estimate of functional data when missing values, and mainly long gaps, are present in the original data set, some procedures are here proposed considering jointly Functional Data Analysis and Empirical Orthogonal Function approaches. In order to compare and validate the proposed procedures, a simulation plan is carried out and some performance indicators are computed. The obtained results show that one of the proposed procedures works better than the others, providing a better reconstruction especially in presence of long gaps.

Multivariate statisticsComputer scienceFunctional data analysisEmpirical orthogonal functionsMissing datacomputer.software_genreEnvironmental dataEOF FDA Missing data Environmental dataSet (abstract data type)Singular value decompositionPerformance indicatorData miningSettore SECS-S/01 - Statisticacomputer
researchProduct

A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice

2021

Translational animal models for studying post-traumatic stress disorder (PTSD) are valuable for elucidating the poorly understood neurobiology of this neuropsychiatric disorder. These models should encompass crucial features, including persistence of PTSD-like phenotypes triggered after exposure to a single traumatic event, trauma susceptibility/resilience and predictive validity. Here we propose a novel arousal-based individual screening (AIS) model that recapitulates all these features. The AIS model was designed by coupling the traumatization (24 h restraint) of C57BL/6 J mice with a novel individual screening. This screening consists of z-normalization of post-trauma changes in startle …

Physiology5-trial SM 5-trial social memoryBiochemistryFight-or-flight responseFST forced swim test0302 clinical medicineEndocrinologySSRIs selective serotonin reuptake inhibitorsDSM-5 Diagnostic and Statistical Manual of Mental DisordersOriginal Research ArticleFear conditioningmedia_commonHT hypothalamusAIS arousal-based individual screeningQP351-495ParoxetinePhenotypeHPA hypothalamic–pituitary–adrenalBST basal synaptic transmissionHIP hippocampusPTSD post-traumatic stress disorder[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Psychological resilienceAmy amygdalaRC321-571medicine.drugNeurophysiology and neuropsychologymedia_common.quotation_subjectBDNF brain derived neurotropic factorFear conditioningNeurosciences. Biological psychiatry. NeuropsychiatryBiologyStressArousal03 medical and health sciencesCellular and Molecular NeuroscienceAnimal model Fear conditioning Resilience Stress Susceptibility Z-scoreAnimal modelCORT corticosteroneOF open fieldTE trauma-exposedBiological neural networkmedicineAnimal model[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]C controlfEPSPs field excitatory post-synaptic potentialsSGK1 serum/glucocorticoid-regulated kinase 1RC346-429Molecular BiologyResilienceEndocrine and Autonomic SystemsZ-scoremPFC medial prefrontal cortexFKBP5 FK506 binding protein 5FDA Food and Drug AdministrationASR acoustic startle reactivityEPM elevated plus maze030227 psychiatrySusceptibilityAnimal model; Fear conditioning; Resilience; Stress; Susceptibility; Z-scoreNeurology. Diseases of the nervous systemNeuroscience030217 neurology & neurosurgeryNeurobiology of Stress
researchProduct

EOFs for gap filling in multivariate air quality data: a FDA approach

2010

Missing values are a common concern in spatiotemporal data sets. During recent years a great number of methods have been developed for gap filling. One of the emerging approaches is based on the Empirical Orthogonal Function (EOF) methodology, applied mainly on raw and univariate data sets presenting irregular missing patterns. In this paper EOF is carried out on a multivariate space-time data set, related to concentrations of pollutants recorded at different sites, after denoising raw data by FDA approach. Some performance indicators are computed on simulated incomplete data sets with also long gaps in order to show that the EOF reconstruction appears to be an improved procedure especially…

Settore SECS-S/01 - StatisticaFDA EOF missing data gap filling
researchProduct